EUVIMEDEUVIMED entdecken
Crossref

Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension

Yandong Pei iD, Dongfeng Ren iD, Yuanhao Yin iD, Jiajia Shi iD, Qianyuan Ai iD, Wenxin Hao iD, Xiaofan Luo, Chenyue Zhang, Yanping Zhao, Chenyu Bai iD, Lin Zhu, Qiong Wang iD und 16 weitere

Circulation Research · 17.01.2025 · 136 (2)

DOI: 10.1161/circresaha.124.325156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 17.01.2025. Verfasst von Yandong Pei und 27 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemistry Biology, Haihe Laboratory of Cell Ecosystem, College of Life Sciences (Y.P., D.R., Y.Y., J.S., Q.A., W.H.…. Hauptthemen laut MEDLINE: Mitochondrial Proteins, Hypertension, Pulmonary, Endothelial Cells, Membrane Proteins. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary hypertension (PH) is associated with endothelial dysfunction. However, the cause of endothelial dysfunction and its impact on PH remain incompletely understood. We aimed to investigate whether the hypoxia-inducible FUNDC1 (FUN14 domain-containing 1)-dependent mitophagy pathway underlies PH pathogenesis and progression. METHODS: We first analyzed FUNDC1 protein levels in lung samples from patients with PH and animal models. Using rodent PH models induced by HySu (hypoxia+SU5416) or chronic hypoxia, we further investigated PH pathogenesis and development in response to global and cell-type-specific Fundc1 loss/gain-of-function. We also investigated the spontaneous PH in mice with inducible loss of endothelial Fundc1 . In addition, histological, metabolic, and transcriptomic studies were performed to delineate molecular mechanisms. Finally, findings were validated in vivo by compound deficiency of HIF2α (hypoxia-inducible factor 2α; Epas1 ) and pharmacological intervention. RESULTS: FUNDC1 protein levels were reduced in PH lung vessels from clinical subjects and animal models. Global Fundc1 deficiency exacerbated PH, while its overexpression was protective. The effect of FUNDC1 was mediated by endothelial cells rather than smooth muscle cells. Further, inducible loss of endothelial Fundc1 in postnatal mice was sufficient to cause PH spontaneously, whereas augmenting endothelial Fundc1 protected against PH before and after the onset of disease. Mechanistically, Fundc1 deficiency impaired basal mitophagy in endothelial cells, leading to the accumulation of dysfunctional mitochondria, metabolic reprogramming toward aerobic glycolysis, pseudohypoxia, and senescence, likely via a mtROS-HIF2α signaling pathway. Subsequently, Fundc1 -deficient endothelial cells increased IGFBP2 (insulin-like growth factor-binding protein 2) secretion that drove pulmonary arterial remodeling to instigate PH. Finally, proof-of-principle in vivo studies showed significant efficacy on PH amelioration by targeting endothelial mitophagy, pseudohypoxia, senescence, or IGFBP2. CONCLUSIONS: Collectively, we show that FUNDC1-mediated basal mitophagy is critical for endothelial homeostasis, and its disruption instigates PH pathogenesis. Given that similar changes in FUNDC1 and IGFBP2 were observed in PH patients, our findings are of significant clinical relevance and provide novel therapeutic strategies for PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial ProteinsHypertension, PulmonaryEndothelial CellsMembrane ProteinsAnimalsHumansMitophagyMiceMaleDisease Models, AnimalFemaleMice, Inbred C57BLBasic Helix-Loop-Helix ProteinsMice, KnockoutLungHypoxiaEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

endothelial cellshypertension, pulmonaryhypoxiainsulin-like peptidesmitophagy

Substanzen

Mitochondrial ProteinsMembrane ProteinsBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1FUNDC1 protein, humanFUNDC1 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemistry Biology, Haihe Laboratory of Cell Ecosystem, College of Life Sciences (Y.P., D.R., Y.Y., J.S., Q.A., W.H., X. Luo, C.B., L. Zhu, Q.W., S.L., Y. Zhang, J.L., L.L., H.Z., Y.L.,…
  • School of Statistics and Data Science, LPMC and KLMDASR (C.Z., Y. Zhao, G.H.), Nankai University, China.
  • Department of Cardiology, Tongji Hospital, Tongji University, China (L. Zhou).
  • Department of Anesthesiology (Y. Wu, Y. Weng), Tianjin First Central Hospital, China.
  • Department of Cardiology (Y.J., C.L.), Tianjin First Central Hospital, China.
  • School of Medical Laboratory, Tianjin Medical University, China (Y.C.).

ORCID-Profile: Yandong Pei, Dongfeng Ren, Yuanhao Yin, Jiajia Shi, Qianyuan Ai, Wenxin Hao, Chenyu Bai, Qiong Wang, Lin Liu, Yuli Wu, Yiqi Weng, Yongle Jing, Chengzhi Lu, Yujie Cui, Yanjun Li, Gang Hu

Zitieren

APA

Pei, Y., Ren, D., Yin, Y., Shi, J., Ai, Q., Hao, W., Luo, X., Zhang, C., Zhao, Y., Bai, C., Zhu, L., Wang, Q., Li, S., Zhang, Y., Lu, J., Liu, L., Zhou, L., Wu, Y., Weng, Y., …, & Liao, X. (2025). Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension. Circulation Research, 136(2). https://doi.org/10.1161/circresaha.124.325156

Vancouver

Pei Y, Ren D, Yin Y, Shi J, Ai Q, Hao W, et al. Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension. Circulation Research. 2025;136(2). doi:10.1161/circresaha.124.325156

BibTeX
@article{Pei2025,
  author = {Pei, Yandong and Ren, Dongfeng and Yin, Yuanhao and Shi, Jiajia and Ai, Qianyuan and Hao, Wenxin and Luo, Xiaofan and Zhang, Chenyue and Zhao, Yanping and Bai, Chenyu and Zhu, Lin and Wang, Qiong and Li, Shuangling and Zhang, Yuwei and Lu, Jiangtao and Liu, Lin and Zhou, Lin and Wu, Yuli and Weng, Yiqi and Jing, Yongle and Lu, Chengzhi and Cui, Yujie and Zheng, Hao and Li, Yanjun and Chen, Guo and Hu, Gang and Chen, Quan and Liao, Xudong},
  title = {Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension},
  journal = {Circulation Research},
  year = {2025},
  volume = {136},
  number = {2},
  doi = {10.1161/circresaha.124.325156}
}
Kostenlos starten →